Form 4: GRAIL Director William Chase Acquires 533 Shares Through Deferred Stock Plan

GRAIL, Inc. Director William J. Chase acquired 533 shares of common stock on July 15, 2025, as part of a deferred stock unit grant in lieu of cash fees.

Summary

• William J. Chase, a Director of GRAIL, Inc., acquired 533 shares of common stock.
• The acquisition occurred on July 15, 2025, at a price of $38.53 per share.
• These shares represent deferred stock units granted under GRAIL's deferred stock program and 2024 Equity Incentive Plan.
• The grant was in lieu of $20,568.49 in cash fees payable to Mr. Chase for his director services.
• The awards vested immediately upon the grant date.
• Following this transaction, Mr. Chase directly beneficially owns 36,315 shares of GRAIL common stock.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transaction is a routine compensation event, but the director's choice to take equity over cash can be seen as a positive signal of confidence in the company's future.

Positives

• Director William J. Chase opted to receive equity (533 shares) instead of cash fees, indicating alignment of his interests with shareholders.
• The immediate vesting of the deferred stock units suggests a clear and immediate transfer of ownership and incentive.

Future Outlook

NA

Industry Context

This is a routine insider transaction where a director receives equity as part of their compensation, a common practice across industries to align management interests with shareholder value. It does not provide broader industry trends.

Comparison to Industry Standards

• Director compensation often includes a mix of cash and equity. Receiving deferred stock units in lieu of cash fees is a standard practice for non-employee directors in many publicly traded companies, including those in the biotechnology or healthcare sector like GRAIL, Inc.
• This aligns the director's financial interests with the long-term performance of the company, similar to practices at companies like Illumina (which previously sought to acquire GRAIL) or other biotech firms where equity compensation is prevalent.

Corporate Governance

Related Party Transactions

• The transaction involves the grant of 533 deferred stock units to William J. Chase, a Director of GRAIL, Inc., in lieu of cash fees for his service. This is a compensation arrangement with a related party (an executive officer or director).

Stakeholder Impact

• Shareholders: The transaction increases the director's equity stake, potentially aligning his interests more closely with shareholders. It also slightly dilutes existing shares, though the amount is negligible.

Key Dates

Recommendation

Keywords

GRAIL Inc., GRAL, SEC Form 4, Insider Trading, Director Compensation, Equity Incentive Plan, Deferred Stock Units, Stock Acquisition, Beneficial Ownership